Literature DB >> 8243869

The BBZ/Wor rat: clinical characteristics of the diabetic syndrome.

D L Guberski1, L Butler, S M Manzi, M Stubbs, A A Like.   

Abstract

The BBZ/Wor rat is a model of obesity and autoimmune diabetes mellitus developed by crossing the BB/Wor and Zucker rats. We studied circulating glucose and insulin levels, islet morphology and lymphocyte subsets in lean and obese BBZ/Wor rats before and after the onset of diabetes, and studied the clinical course of diabetes in animals after interruption of exogenous insulin therapy. Lean BBZ/Wor rats developed insulin-dependent diabetes and died in ketoacidosis within 1 week after cessation of insulin injections. Diabetes also developed in obese rats, but these animals were not insulin-dependent and survived for months without insulin therapy. The islets of the lean diabetic rats revealed complete destruction of pancreatic beta cells and plasma insulin levels were virtually undetectable. In contrast, the islets of the obese rats revealed insulitis and substantial beta-cell loss, however autoimmune beta-cell destruction was incomplete, and residual beta cells were presumably responsible for the presence of measurable levels of plasma insulin and the long-term survival of obese diabetics without insulin therapy. Obese rats were hyperinsulinaemic, developed diabetes significantly earlier, and with a greater incidence than lean rats, suggesting a possible relationship between enhanced beta-cell metabolic activity and immune destruction. Obese males became diabetic more frequently and at an earlier age than obese females and lean rats of both sexes, suggesting a role for gender in the pathogenesis of diabetes. We conclude that the BBZ/Wor rat is a unique animal model for investigating the interaction of obesity, beta-cell metabolism, autoimmune insulitis and genetic predisposition to diabetes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243869     DOI: 10.1007/bf02374472

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Prevention of spontaneous diabetes in BB rats with FK 506.

Authors:  N Murase; I Lieberman; M Nalesnik; D Mintz; S Todo; A L Drash; T E Starzl
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

2.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 3.  Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies.

Authors:  D W Mason; R P Arthur; M J Dallman; J R Green; G P Spickett; M L Thomas
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies.

Authors:  B A Woda; M L McFadden; R M Welsh; K M Bain
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

5.  Natural killer cell depletion and diabetes mellitus in the BB/Wor rat (revisited).

Authors:  K Ellerman; M Wrobleski; A Rabinovitch; A Like
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

6.  Direct assessment of the role of NK cells in autoimmune diabetes.

Authors:  M S Shachner; J F Markmann; H Bassiri; J I Kim; A Naji; C F Barker
Journal:  J Surg Res       Date:  1992-06       Impact factor: 2.192

7.  Insulin and obesity in the Zucker genetically obese rat "fatty".

Authors:  L M Zucker; H N Antoniades
Journal:  Endocrinology       Date:  1972-05       Impact factor: 4.736

Review 8.  The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.

Authors:  B L Kasiske; M P O'Donnell; W F Keane
Journal:  Hypertension       Date:  1992-01       Impact factor: 10.190

9.  Diabetic BioBreeding/Worcester (BB/Wor) rats need not be lymphopenic.

Authors:  A A Like; D L Guberski; L Butler
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

10.  Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells.

Authors:  A A Like; C A Biron; E J Weringer; K Byman; E Sroczynski; D L Guberski
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Diabetes, obesity and erectile dysfunction: field overview and research priorities.

Authors:  Kanchan Chitaley; Varant Kupelian; Leslee Subak; Hunter Wessells
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

2.  Myogenic tone and reactivity of cerebral arteries in type II diabetic BBZDR/Wor rat.

Authors:  Yagna P R Jarajapu; Dennis L Guberski; Maria B Grant; Harm J Knot
Journal:  Eur J Pharmacol       Date:  2007-10-25       Impact factor: 4.432

3.  Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells.

Authors:  Sergio Caballero; Nilanjana Sengupta; Aqeela Afzal; Kyung-Hee Chang; Sergio Li Calzi; Dennis L Guberski; Timothy S Kern; Maria B Grant
Journal:  Diabetes       Date:  2007-04       Impact factor: 9.461

4.  Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice.

Authors:  Masaki Naito; Junji Fujikura; Ken Ebihara; Fumiko Miyanaga; Hideki Yokoi; Toru Kusakabe; Yuji Yamamoto; Cheol Son; Masashi Mukoyama; Kiminori Hosoda; Kazuwa Nakao
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461

5.  4-Nitroquinoline 1-Oxide-Induced Tongue and Esophagus Carcinogenesis in Obese and Diabetic TSOD Mice.

Authors:  Takuji Tanaka; Kunihiro Kawabata; Shigeyuki Sugie
Journal:  World J Oncol       Date:  2017-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.